Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury
详细信息 查看全文
- 作者：Mehmet Kanbay ; Marc Vervloet ; Mario Cozzolino…
- 关键词：Fibroblast growth factor 23 ; Insulin resistance ; Proteinuria ; Inflammation ; Acute kidney injury ; Left ventricular hypertrophy
- 刊名：Calcified Tissue International
- 出版年：2017
- 出版时间：March 2017
- 年：2017
- 卷：100
- 期：3
- 页码：217-228
- 全文大小：
- 刊物类别：Biomedical and Life Sciences
- 刊物主题：Biochemistry, general; Endocrinology; Orthopedics; Cell Biology;
- 出版者：Springer US
- ISSN：1432-0827
- 卷排序：100
文摘
FGF23 is a hormone that appears as the core regulator of phosphate metabolism. Great deal of data has accumulated to demonstrate increased FGF23 secretion from the bone to compensate for even subtle increases in serum phosphorus long before intact PTH. However, recent evidence points to the fact that actions and interactions of FGF23 are not limited solely to phosphate metabolism. FGF23 may be implicated in iron metabolism and erythropoiesis, inflammation, insulin resistance, proteinuria, acute kidney injury and left ventricular hypertrophy. In this review, we will summarize latest experimental and clinical data examining impact of FGF23 on aforementioned pathophysiologic pathways/disorders.